US biopharmaceutical firm Apollomics raises $124m led by Ping An Capital

US biopharmaceutical firm Apollomics raises $124m led by Ping An Capital

Photo: Bloomberg

06 November, 2020

Apollomics OrbiMed Asia Ping An Capital

Printed by Unregistered user on Fri, 04 Jul 2025 23:21:57 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

CMB International leads $100m funding in US biopharma firm Apollomics

China's Lepu Biotech snags $186m Series B co-led by Ping An Capital

Read more from Greater China

China’s EV rivalry spills over to Thailand, tests local production goals

People Digest: responsAbility appoints CEO; Gaw Capital names data centre platform head